 Connection
Stanley Szefler to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Stanley Szefler has written about Clinical Trials, Phase III as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.206 |
|
|
|
-
Hamelmann E, Vogelberg C, Szefler SJ. Tiotropium for the treatment of asthma in adolescents. Expert Opin Pharmacother. 2017 Feb; 18(3):305-312.
Score: 0.134
-
Pavord ID, Rabe KF, Israel E, Szefler SJ, Brusselle G, Pandit-Abid N, Altincatal A, Chen Z, Amin N, Khan AH, Lederer DJ, Zhang Y, Rowe PJ, Deniz Y, Radwan A, Jacob-Nara JA, Busse WW. Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma. J Allergy Clin Immunol Pract. 2025 Jan; 13(1):132-142.
Score: 0.057
-
Chinchilli VM, Phillips BR, Mauger DT, Szefler SJ. A general class of correlation coefficients for the 2 x 2 crossover design. Biom J. 2005 Oct; 47(5):644-53.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|